Clinical Trial Update: Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD [Phase 3]

View source ↗

Summary

Phase III study assessing safety and efficacy of ilaprazole in non-erosive reflux disease is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Reflux Disease

Drugs mentioned

• Ilaprazole (ilaprazole)

Snippet

Sponsor: Il-Yang Pharm. Co., Ltd. | Conditions: Non-erosive Reflux Disease | Phase 3 | Status: COMPLETED